SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-18-003974
Filing Date
2018-04-16
Accepted
2018-04-16 16:25:00
Documents
41
Period of Report
2018-02-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT qbio-0228201810q04122018c.htm 10-Q 416296
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit31.htm EX-31.1 19504
3 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE exhibit32.htm EX-32.1 8356
  Complete submission text file 0001654954-18-003974.txt   1459798

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT qbio-20180228.xml EX-101.INS 147546
5 XBRL TAXONOMY EXTENSION SCHEMA qbio-20180228.xsd EX-101.SCH 20585
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qbio-20180228_cal.xml EX-101.CAL 25187
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qbio-20180228_def.xml EX-101.DEF 21538
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE qbio-20180228_lab.xml EX-101.LAB 135057
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qbio-20180228_pre.xml EX-101.PRE 95871
Mailing Address 501 MADISON AVE. 14TH FLOOR NEW YORK NY 10022
Business Address 501 MADISON AVE. 14TH FLOOR NEW YORK NY 10022 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 000-55535 | Film No.: 18756873
SIC: 2834 Pharmaceutical Preparations